Classification of antiarrhythmic drugs

Area of Science:

• Pharmacology
• Cardiology
• Electrophysiology

Background:

• Multiple classification schemes for antiarrhythmic drugs exist.
• The Vaughan Williams system, modified by Harrison, is widely accepted.
• This system categorizes drugs based on their electrophysiologic effects.

Purpose of the Study:

• To review the widely accepted Vaughan Williams classification of antiarrhythmic drugs.
• To discuss the electrophysiologic basis of this classification.
• To evaluate the strengths and weaknesses of the system.

Main Methods:

• Review of existing literature on antiarrhythmic drug classification.
• Analysis of the Vaughan Williams classification system.
• Discussion of electrophysiologic mechanisms and clinical observations.

Main Results:

• The Vaughan Williams system classifies drugs into four main categories: Class I (sodium channel blockers), Class II (beta-blockers), Class III (action potential prolongers), and Class IV (calcium channel blockers).
• The classification is largely based on clinical observation.
• The system has remained useful for nearly two decades.

Conclusions:

• The Vaughan Williams classification provides a valuable framework for understanding antiarrhythmic drugs.
• Despite its age, the system's basis in clinical observation ensures its continued relevance.
• Further discussion on its electrophysiologic underpinnings, strengths, and limitations is warranted.